- Home
- DRIO vs FLGC Comparison
DRIO vs FLGC Comparison
Compare DRIO & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- FLGC
- Stock Information
- Founded
- DRIO 2011
- FLGC 2019
- Country
- DRIO United States
- FLGC United States
- Employees
- DRIO N/A
- FLGC N/A
- Industry
- DRIO Medical/Dental Instruments
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- FLGC Health Care
- Exchange
- DRIO Nasdaq
- FLGC Nasdaq
- Market Cap
- DRIO 25.1M
- FLGC 26.5M
- IPO Year
- DRIO N/A
- FLGC 2021
- Fundamental
- Price
- DRIO $0.84
- FLGC $1.37
- Analyst Decision
- DRIO Strong Buy
- FLGC Strong Buy
- Analyst Count
- DRIO 1
- FLGC 3
- Target Price
- DRIO $4.00
- FLGC $6.50
- AVG Volume (30 Days)
- DRIO 61.5K
- FLGC 515.7K
- Earning Date
- DRIO 11-07-2024
- FLGC 11-13-2024
- Dividend Yield
- DRIO N/A
- FLGC N/A
- EPS Growth
- DRIO N/A
- FLGC N/A
- EPS
- DRIO N/A
- FLGC N/A
- Revenue
- DRIO $23,052,000.00
- FLGC $64,154,000.00
- Revenue This Year
- DRIO $36.66
- FLGC N/A
- Revenue Next Year
- DRIO $35.35
- FLGC $19.90
- P/E Ratio
- DRIO N/A
- FLGC N/A
- Revenue Growth
- DRIO N/A
- FLGC N/A
- 52 Week Low
- DRIO $0.71
- FLGC $0.75
- 52 Week High
- DRIO $2.60
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- DRIO 47.40
- FLGC 47.10
- Support Level
- DRIO $0.78
- FLGC $1.19
- Resistance Level
- DRIO $0.95
- FLGC $1.36
- Average True Range (ATR)
- DRIO 0.07
- FLGC 0.12
- MACD
- DRIO -0.01
- FLGC -0.00
- Stochastic Oscillator
- DRIO 49.16
- FLGC 43.16
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.